Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 165

Similar articles for PubMed (Select 21724708)

1.

Plectranthus amboinicus attenuates inflammatory bone erosion in mice with collagen-induced arthritis by downregulation of RANKL-induced NFATc1 expression.

Hsu YC, Cheng CP, Chang DM.

J Rheumatol. 2011 Sep;38(9):1844-57. doi: 10.3899/jrheum.101223. Epub 2011 Jul 1.

PMID:
21724708
2.

A benzamide-linked small molecule NDMC101 inhibits NFATc1 and NF-κB activity: a potential osteoclastogenesis inhibitor for experimental arthritis.

Cheng CP, Huang HS, Hsu YC, Sheu MJ, Chang DM.

J Clin Immunol. 2012 Aug;32(4):762-77. doi: 10.1007/s10875-012-9660-9. Epub 2012 Feb 23.

PMID:
22396044
3.

Defining the mechanism of action of herbal therapies in rheumatoid arthritis: is this the road to clinical development and acceptance?

Mookherjee N, El-Gabalawy H.

J Rheumatol. 2011 Sep;38(9):1817-9. doi: 10.3899/jrheum.110823. No abstract available.

PMID:
21885502
4.

Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.

Takatsuna H, Asagiri M, Kubota T, Oka K, Osada T, Sugiyama C, Saito H, Aoki K, Ohya K, Takayanagi H, Umezawa K.

J Bone Miner Res. 2005 Apr;20(4):653-62. Epub 2004 Dec 6.

PMID:
15765185
5.

Inclusion criteria based on DAS28 score: strength of improvement is less dependent on baseline disease activity than expected.

van der Horst-Bruinsma I.

J Rheumatol. 2011 Sep;38(9):1820. doi: 10.3899/jrheum.110928. No abstract available.

PMID:
21885503
6.

Decoy receptor 3 suppresses RANKL-induced osteoclastogenesis via down-regulating NFATc1 and enhancing cell apoptosis.

Cheng CP, Sheu MJ, Sytwu HK, Chang DM.

Rheumatology (Oxford). 2013 Apr;52(4):609-22. doi: 10.1093/rheumatology/kes343. Epub 2012 Dec 7.

8.

Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression.

Kwak HB, Lee BK, Oh J, Yeon JT, Choi SW, Cho HJ, Lee MS, Kim JJ, Bae JM, Kim SH, Kim HS.

Bone. 2010 Mar;46(3):724-31. doi: 10.1016/j.bone.2009.10.042. Epub 2009 Nov 6.

PMID:
19900598
9.

Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.

Kim SD, Kim HN, Lee JH, Jin WJ, Hwang SJ, Kim HH, Ha H, Lee ZH.

Biochem Pharmacol. 2013 Sep 15;86(6):782-90. doi: 10.1016/j.bcp.2013.07.015. Epub 2013 Aug 6.

PMID:
23928189
10.

Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.

Lubberts E, Oppers-Walgreen B, Pettit AR, Van Den Bersselaar L, Joosten LA, Goldring SR, Gravallese EM, Van Den Berg WB.

Arthritis Rheum. 2002 Nov;46(11):3055-64.

11.

Nordihydroguaiaretic acid inhibition of NFATc1 suppresses osteoclastogenesis and arthritis bone destruction in rats.

Li YJ, Kukita A, Watanabe T, Takano T, Qu P, Sanematsu K, Ninomiya Y, Kukita T.

Lab Invest. 2012 Dec;92(12):1777-87. doi: 10.1038/labinvest.2012.134. Epub 2012 Oct 8.

12.

Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.

Kamel Mohamed SG, Sugiyama E, Shinoda K, Hounoki H, Taki H, Maruyama M, Miyahara T, Kobayashi M.

Biochem Biophys Res Commun. 2005 Apr 15;329(3):839-45.

PMID:
15752732
13.

Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells.

Lee JW, Iwahashi A, Hasegawa S, Yonezawa T, Jeon WB, Cha BY, Nagai K, Woo JT.

J Nat Med. 2012 Jan;66(1):8-16. doi: 10.1007/s11418-011-0537-7. Epub 2011 Jun 9.

PMID:
21656335
14.

Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.

Tsuji-Naito K.

Bioorg Med Chem. 2008 Oct 15;16(20):9176-83. doi: 10.1016/j.bmc.2008.09.036. Epub 2008 Sep 14.

PMID:
18823786
15.

RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines.

Naidu VG, Dinesh Babu KR, Thwin MM, Satish RL, Kumar PV, Gopalakrishnakone P.

Chem Biol Interact. 2013 Apr 25;203(2):467-79. doi: 10.1016/j.cbi.2012.12.016. Epub 2013 Jan 17.

PMID:
23333834
16.

Treatment with anti-gamma-glutamyl transpeptidase antibody attenuates osteolysis in collagen-induced arthritis mice.

Ishizuka Y, Moriwaki S, Kawahara-Hanaoka M, Uemura Y, Serizawa I, Miyauchi M, Shibata S, Kanaya T, Takata T, Taniguchi N, Niida S.

J Bone Miner Res. 2007 Dec;22(12):1933-42.

PMID:
17680722
17.

Grape seed proanthocyanidin extract (GSPE) attenuates collagen-induced arthritis.

Cho ML, Heo YJ, Park MK, Oh HJ, Park JS, Woo YJ, Ju JH, Park SH, Kim HY, Min JK.

Immunol Lett. 2009 Jun 4;124(2):102-10. doi: 10.1016/j.imlet.2009.05.001. Epub 2009 May 14.

PMID:
19446580
18.

Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kappaB activation.

Hirayama T, Dai S, Abbas S, Yamanaka Y, Abu-Amer Y.

Arthritis Rheum. 2005 Sep;52(9):2719-29.

19.

Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.

Mohamed SG, Sugiyama E, Shinoda K, Taki H, Hounoki H, Abdel-Aziz HO, Maruyama M, Kobayashi M, Ogawa H, Miyahara T.

Bone. 2007 Oct;41(4):592-602. Epub 2007 Jun 13.

PMID:
17627913
20.

Taurine chloramine inhibits osteoclastogenesis and splenic lymphocyte proliferation in mice with collagen-induced arthritis.

Wang Y, Cha YN, Kim KS, Kim C.

Eur J Pharmacol. 2011 Oct 1;668(1-2):325-30. doi: 10.1016/j.ejphar.2011.07.017. Epub 2011 Jul 28.

PMID:
21816143
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk